Busy, and productive, week with our current MSc by Research student, CAIT BELLAMY, and Summer Placement Student, @snathanm247, within Swansea Worm Integrative Research Laboratory (SWIRL) @SwanseaMedicine, Swansea University - developing new assays for ethanol studies in vivo!

So proud of our students Shaurya Nathan Mathur, Julanta and CAIT BELLAMY for their poster 'concentration-dependent behavioural effects of ethanol in the novel in vivo organism, Lumbriculus variegatus' presented at #Pharmacology2021 British Pharmacological Society.

Well done Shaurya Nathan Mathur, Julanta, CAIT BELLAMY, Dr Nia Davies. Great to see this iPoster contribution to #Pharmacology2021 British Pharmacological Society up and available for viewing.

Please help slow the spread of #COVID19 and identify at risk cases sooner by self-reporting your symptoms daily, even if you feel well, and #getvaccinated if you’re able to 🙂 #ProtectTheNHS💙#StaySafeAndSaveLives covid.joinzoe.com

Huge thank you to everyone that donated to my #Movember fundraiser ❤️ movember.com/m/14682497?mc=1

Today we published the first analysis in over 10 years looking at which ethnic groups in England are more likely to get cancer 👥 Addressing cancer inequalities needs to be central to @SajidJavid’s new 10-year cancer plan. Here’s why 👇 1/5 bit.ly/3MppoMf

Added one more to my little collection yesterday 📚 #WorldBookDay

Together with Royal College of Physicians we launch a report today that we hope will make #PersonalisedPrescribing a reality for patients, reducing side effects & the financial burden on the NHS. We call for #pharmacogenomic testing to be embedded in the NHS. 💊🧬 ow.ly/ff5e50IuIoj

Scientists in the Telomere-to-Telomere (#T2T) consortium have published the first complete, gapless human genome sequence. This can lead to a better understanding of our genomic variations and provide insight for missing heritability and human disease. genome.gov/T2T

Thoroughly enjoyed and learned a lot from attending talks on Cancer Genomics, Emerging Technologies (Bioinformatics/AI-ML) and Rare Diseases at Genomics England #GERS2022 conference today 🧬